BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21880674)

  • 1. Integration of 3D electroanatomic maps and magnetic resonance scar characterization into the navigation system to guide ventricular tachycardia ablation.
    Andreu D; Berruezo A; Ortiz-Pérez JT; Silva E; Mont L; Borràs R; de Caralt TM; Perea RJ; Fernández-Armenta J; Zeljko H; Brugada J
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):674-83. PubMed ID: 21880674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: insights for ventricular tachycardia ablation.
    Fernández-Armenta J; Berruezo A; Andreu D; Camara O; Silva E; Serra L; Barbarito V; Carotenutto L; Evertz R; Ortiz-Pérez JT; De Caralt TM; Perea RJ; Sitges M; Mont L; Frangi A; Brugada J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):528-37. PubMed ID: 23685537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation.
    Andreu D; Ortiz-Pérez JT; Fernández-Armenta J; Guiu E; Acosta J; Prat-González S; De Caralt TM; Perea RJ; Garrido C; Mont L; Brugada J; Berruezo A
    Europace; 2015 Jun; 17(6):938-45. PubMed ID: 25616406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging.
    Codreanu A; Odille F; Aliot E; Marie PY; Magnin-Poull I; Andronache M; Mandry D; Djaballah W; Régent D; Felblinger J; de Chillou C
    J Am Coll Cardiol; 2008 Sep; 52(10):839-42. PubMed ID: 18755347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators.
    Dickfeld T; Tian J; Ahmad G; Jimenez A; Turgeman A; Kuk R; Peters M; Saliaris A; Saba M; Shorofsky S; Jeudy J
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):172-84. PubMed ID: 21270103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial substrate mapping for ventricular tachycardia ablation in patients with non-ischaemic cardiomyopathy: a new algorithm to differentiate between scar and viable myocardium developed by simultaneous integration of computed tomography and contrast-enhanced magnetic resonance imaging.
    Piers SR; van Huls van Taxis CF; Tao Q; van der Geest RJ; Askar SF; Siebelink HM; Schalij MJ; Zeppenfeld K
    Eur Heart J; 2013 Feb; 34(8):586-96. PubMed ID: 23161702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac magnetic resonance-aided scar dechanneling: Influence on acute and long-term outcomes.
    Andreu D; Penela D; Acosta J; Fernández-Armenta J; Perea RJ; Soto-Iglesias D; de Caralt TM; Ortiz-Perez JT; Prat-González S; Borràs R; Guasch E; Tolosana JM; Mont L; Berruezo A
    Heart Rhythm; 2017 Aug; 14(8):1121-1128. PubMed ID: 28760258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of 3-dimensional scar models from SPECT to guide ventricular tachycardia ablation.
    Tian J; Smith MF; Ahmad G; Dilsizian V; Jimenez A; Dickfeld T
    J Nucl Med; 2012 Jun; 53(6):894-901. PubMed ID: 22577237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of merged delayed-enhanced magnetic resonance imaging and multidetector computed tomography for the guidance of ventricular tachycardia ablation: a pilot study.
    Cochet H; Komatsu Y; Sacher F; Jadidi AS; Scherr D; Riffaud M; Derval N; Shah A; Roten L; Pascale P; Relan J; Sermesant M; Ayache N; Montaudon M; Laurent F; Hocini M; Haïssaguerre M; Jaïs P
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):419-26. PubMed ID: 23252727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of bipolar and unipolar electrogram voltage to scar transmurality and composition derived by magnetic resonance imaging in patients with nonischemic cardiomyopathy undergoing VT ablation.
    Spears DA; Suszko AM; Dalvi R; Crean AM; Ivanov J; Nanthakumar K; Downar E; Chauhan VS
    Heart Rhythm; 2012 Nov; 9(11):1837-46. PubMed ID: 22846338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of three-dimensional scar maps for ventricular tachycardia ablation with positron emission tomography-computed tomography.
    Dickfeld T; Lei P; Dilsizian V; Jeudy J; Dong J; Voudouris A; Peters R; Saba M; Shekhar R; Shorofsky S
    JACC Cardiovasc Imaging; 2008 Jan; 1(1):73-82. PubMed ID: 19356409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-head comparison of contrast-enhanced magnetic resonance imaging and electroanatomical voltage mapping to assess post-infarct scar characteristics in patients with ventricular tachycardias: real-time image integration and reversed registration.
    Wijnmaalen AP; van der Geest RJ; van Huls van Taxis CF; Siebelink HM; Kroft LJ; Bax JJ; Reiber JH; Schalij MJ; Zeppenfeld K
    Eur Heart J; 2011 Jan; 32(1):104-14. PubMed ID: 20864488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic Detection of Slow Conducting Channels during Substrate Ablation of Scar-Related Ventricular Arrhythmias.
    Alcaine A; Jáuregui B; Soto-Iglesias D; Acosta J; Penela D; Fernández-Armenta J; Linhart M; Andreu D; Mont L; Laguna P; Camara O; Martínez JP; Berruezo A
    J Interv Cardiol; 2020; 2020():4386841. PubMed ID: 32549801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional 123I-meta-iodobenzylguanidine cardiac innervation maps to assess substrate and successful ablation sites for ventricular tachycardia: feasibility study for a novel paradigm of innervation imaging.
    Klein T; Abdulghani M; Smith M; Huang R; Asoglu R; Remo BF; Turgeman A; Mesubi O; Sidhu S; Synowski S; Saliaris A; See V; Shorofsky S; Chen W; Dilsizian V; Dickfeld T
    Circ Arrhythm Electrophysiol; 2015 Jun; 8(3):583-91. PubMed ID: 25713216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: Implications of varying scar ranges.
    Bhagirath P; Campos FO; Costa CM; Wilde AAM; Prassl AJ; Neic A; Plank G; Rinaldi CA; Götte MJW; Bishop MJ
    Heart Rhythm; 2022 Oct; 19(10):1604-1610. PubMed ID: 35644355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between successful ablation sites and the scar border zone defined by substrate mapping for ventricular tachycardia post-myocardial infarction.
    Verma A; Marrouche NF; Schweikert RA; Saliba W; Wazni O; Cummings J; Abdul-Karim A; Bhargava M; Burkhardt JD; Kilicaslan F; Martin DO; Natale A
    J Cardiovasc Electrophysiol; 2005 May; 16(5):465-71. PubMed ID: 15877614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction.
    Reddy VY; Malchano ZJ; Holmvang G; Schmidt EJ; d'Avila A; Houghtaling C; Chan RC; Ruskin JN
    J Am Coll Cardiol; 2004 Dec; 44(11):2202-13. PubMed ID: 15582319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular scar channel entrances identified by new wideband cardiac magnetic resonance sequence to guide ventricular tachycardia ablation in patients with cardiac defibrillators.
    Roca-Luque I; Van Breukelen A; Alarcon F; Garre P; Tolosana JM; Borras R; Sanchez P; Zaraket F; Doltra A; Ortiz-Perez JT; Prat-Gonzalez S; Perea RJ; Guasch E; Arbelo E; Berruezo A; Sitges M; Brugada J; Mont L
    Europace; 2020 Apr; 22(4):598-606. PubMed ID: 32101605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.